The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chemical CDMO Market Research Report 2024
Synopsis
CDMO, Contract development and manufacturing organization, is an emerging R&D and production outsourcing organization, mainly for the products of medical production enterprises and biotechnology companies, especially the process R&D and preparation of innovative products, process optimization, registration and verification batch production and commercial A service organization for customized R&D and production.
Global Chemical CDMO market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Chemical CDMO market research.
Key companies engaged in the Chemical CDMO industry include Lonza, Catalent, GenScript Biotech, Biosynth, Otsuka Chemical, AGC Pharma Chemicals, Jubilant Bhartia Group, Sinopep Allsino Bio Pharmaceutical and Wuxi Biologics (Cayman), etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Chemical CDMO were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Chemical CDMO market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Chemical CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Lonza
Catalent
GenScript Biotech
Biosynth
Otsuka Chemical
AGC Pharma Chemicals
Jubilant Bhartia Group
Sinopep Allsino Bio Pharmaceutical
Wuxi Biologics (Cayman)
Porton Fine Chemicals
Zhejiang Jiuzhou Pharmaceutical
NYCRIST
Guangzhou Bositao Controlled Release Pharmaceutical
Charles River
Cambrex
Almac Group
Jubilant Pharmova
Cambrex
Siegfried Holding AG
Aenova Group
Samsung BioLogics
Segment by Type
Small Molecule Preparations
Macromolecule Preparations
Segment by Application
Pharmaceutical Company
Biotechnology Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Chemical CDMO report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
CDMO, Contract development and manufacturing organization, is an emerging R&D and production outsourcing organization, mainly for the products of medical production enterprises and biotechnology companies, especially the process R&D and preparation of innovative products, process optimization, registration and verification batch production and commercial A service organization for customized R&D and production.
Global Chemical CDMO market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Chemical CDMO market research.
Key companies engaged in the Chemical CDMO industry include Lonza, Catalent, GenScript Biotech, Biosynth, Otsuka Chemical, AGC Pharma Chemicals, Jubilant Bhartia Group, Sinopep Allsino Bio Pharmaceutical and Wuxi Biologics (Cayman), etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Chemical CDMO were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Chemical CDMO market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Chemical CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Lonza
Catalent
GenScript Biotech
Biosynth
Otsuka Chemical
AGC Pharma Chemicals
Jubilant Bhartia Group
Sinopep Allsino Bio Pharmaceutical
Wuxi Biologics (Cayman)
Porton Fine Chemicals
Zhejiang Jiuzhou Pharmaceutical
NYCRIST
Guangzhou Bositao Controlled Release Pharmaceutical
Charles River
Cambrex
Almac Group
Jubilant Pharmova
Cambrex
Siegfried Holding AG
Aenova Group
Samsung BioLogics
Segment by Type
Small Molecule Preparations
Macromolecule Preparations
Segment by Application
Pharmaceutical Company
Biotechnology Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Chemical CDMO report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemical CDMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Small Molecule Preparations
1.2.3 Macromolecule Preparations
1.3 Market by Application
1.3.1 Global Chemical CDMO Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chemical CDMO Market Perspective (2018-2029)
2.2 Chemical CDMO Growth Trends by Region
2.2.1 Global Chemical CDMO Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Chemical CDMO Historic Market Size by Region (2018-2023)
2.2.3 Chemical CDMO Forecasted Market Size by Region (2024-2029)
2.3 Chemical CDMO Market Dynamics
2.3.1 Chemical CDMO Industry Trends
2.3.2 Chemical CDMO Market Drivers
2.3.3 Chemical CDMO Market Challenges
2.3.4 Chemical CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chemical CDMO Players by Revenue
3.1.1 Global Top Chemical CDMO Players by Revenue (2018-2023)
3.1.2 Global Chemical CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Chemical CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chemical CDMO Revenue
3.4 Global Chemical CDMO Market Concentration Ratio
3.4.1 Global Chemical CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemical CDMO Revenue in 2022
3.5 Chemical CDMO Key Players Head office and Area Served
3.6 Key Players Chemical CDMO Product Solution and Service
3.7 Date of Enter into Chemical CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemical CDMO Breakdown Data by Type
4.1 Global Chemical CDMO Historic Market Size by Type (2018-2023)
4.2 Global Chemical CDMO Forecasted Market Size by Type (2024-2029)
5 Chemical CDMO Breakdown Data by Application
5.1 Global Chemical CDMO Historic Market Size by Application (2018-2023)
5.2 Global Chemical CDMO Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Chemical CDMO Market Size (2018-2029)
6.2 North America Chemical CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Chemical CDMO Market Size by Country (2018-2023)
6.4 North America Chemical CDMO Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chemical CDMO Market Size (2018-2029)
7.2 Europe Chemical CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Chemical CDMO Market Size by Country (2018-2023)
7.4 Europe Chemical CDMO Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chemical CDMO Market Size (2018-2029)
8.2 Asia-Pacific Chemical CDMO Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Chemical CDMO Market Size by Region (2018-2023)
8.4 Asia-Pacific Chemical CDMO Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chemical CDMO Market Size (2018-2029)
9.2 Latin America Chemical CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Chemical CDMO Market Size by Country (2018-2023)
9.4 Latin America Chemical CDMO Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chemical CDMO Market Size (2018-2029)
10.2 Middle East & Africa Chemical CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Chemical CDMO Market Size by Country (2018-2023)
10.4 Middle East & Africa Chemical CDMO Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Chemical CDMO Introduction
11.1.4 Lonza Revenue in Chemical CDMO Business (2018-2023)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Detail
11.2.2 Catalent Business Overview
11.2.3 Catalent Chemical CDMO Introduction
11.2.4 Catalent Revenue in Chemical CDMO Business (2018-2023)
11.2.5 Catalent Recent Development
11.3 GenScript Biotech
11.3.1 GenScript Biotech Company Detail
11.3.2 GenScript Biotech Business Overview
11.3.3 GenScript Biotech Chemical CDMO Introduction
11.3.4 GenScript Biotech Revenue in Chemical CDMO Business (2018-2023)
11.3.5 GenScript Biotech Recent Development
11.4 Biosynth
11.4.1 Biosynth Company Detail
11.4.2 Biosynth Business Overview
11.4.3 Biosynth Chemical CDMO Introduction
11.4.4 Biosynth Revenue in Chemical CDMO Business (2018-2023)
11.4.5 Biosynth Recent Development
11.5 Otsuka Chemical
11.5.1 Otsuka Chemical Company Detail
11.5.2 Otsuka Chemical Business Overview
11.5.3 Otsuka Chemical Chemical CDMO Introduction
11.5.4 Otsuka Chemical Revenue in Chemical CDMO Business (2018-2023)
11.5.5 Otsuka Chemical Recent Development
11.6 AGC Pharma Chemicals
11.6.1 AGC Pharma Chemicals Company Detail
11.6.2 AGC Pharma Chemicals Business Overview
11.6.3 AGC Pharma Chemicals Chemical CDMO Introduction
11.6.4 AGC Pharma Chemicals Revenue in Chemical CDMO Business (2018-2023)
11.6.5 AGC Pharma Chemicals Recent Development
11.7 Jubilant Bhartia Group
11.7.1 Jubilant Bhartia Group Company Detail
11.7.2 Jubilant Bhartia Group Business Overview
11.7.3 Jubilant Bhartia Group Chemical CDMO Introduction
11.7.4 Jubilant Bhartia Group Revenue in Chemical CDMO Business (2018-2023)
11.7.5 Jubilant Bhartia Group Recent Development
11.8 Sinopep Allsino Bio Pharmaceutical
11.8.1 Sinopep Allsino Bio Pharmaceutical Company Detail
11.8.2 Sinopep Allsino Bio Pharmaceutical Business Overview
11.8.3 Sinopep Allsino Bio Pharmaceutical Chemical CDMO Introduction
11.8.4 Sinopep Allsino Bio Pharmaceutical Revenue in Chemical CDMO Business (2018-2023)
11.8.5 Sinopep Allsino Bio Pharmaceutical Recent Development
11.9 Wuxi Biologics (Cayman)
11.9.1 Wuxi Biologics (Cayman) Company Detail
11.9.2 Wuxi Biologics (Cayman) Business Overview
11.9.3 Wuxi Biologics (Cayman) Chemical CDMO Introduction
11.9.4 Wuxi Biologics (Cayman) Revenue in Chemical CDMO Business (2018-2023)
11.9.5 Wuxi Biologics (Cayman) Recent Development
11.10 Porton Fine Chemicals
11.10.1 Porton Fine Chemicals Company Detail
11.10.2 Porton Fine Chemicals Business Overview
11.10.3 Porton Fine Chemicals Chemical CDMO Introduction
11.10.4 Porton Fine Chemicals Revenue in Chemical CDMO Business (2018-2023)
11.10.5 Porton Fine Chemicals Recent Development
11.11 Zhejiang Jiuzhou Pharmaceutical
11.11.1 Zhejiang Jiuzhou Pharmaceutical Company Detail
11.11.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
11.11.3 Zhejiang Jiuzhou Pharmaceutical Chemical CDMO Introduction
11.11.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Chemical CDMO Business (2018-2023)
11.11.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
11.12 NYCRIST
11.12.1 NYCRIST Company Detail
11.12.2 NYCRIST Business Overview
11.12.3 NYCRIST Chemical CDMO Introduction
11.12.4 NYCRIST Revenue in Chemical CDMO Business (2018-2023)
11.12.5 NYCRIST Recent Development
11.13 Guangzhou Bositao Controlled Release Pharmaceutical
11.13.1 Guangzhou Bositao Controlled Release Pharmaceutical Company Detail
11.13.2 Guangzhou Bositao Controlled Release Pharmaceutical Business Overview
11.13.3 Guangzhou Bositao Controlled Release Pharmaceutical Chemical CDMO Introduction
11.13.4 Guangzhou Bositao Controlled Release Pharmaceutical Revenue in Chemical CDMO Business (2018-2023)
11.13.5 Guangzhou Bositao Controlled Release Pharmaceutical Recent Development
11.14 Charles River
11.14.1 Charles River Company Detail
11.14.2 Charles River Business Overview
11.14.3 Charles River Chemical CDMO Introduction
11.14.4 Charles River Revenue in Chemical CDMO Business (2018-2023)
11.14.5 Charles River Recent Development
11.15 Cambrex
11.15.1 Cambrex Company Detail
11.15.2 Cambrex Business Overview
11.15.3 Cambrex Chemical CDMO Introduction
11.15.4 Cambrex Revenue in Chemical CDMO Business (2018-2023)
11.15.5 Cambrex Recent Development
11.16 Almac Group
11.16.1 Almac Group Company Detail
11.16.2 Almac Group Business Overview
11.16.3 Almac Group Chemical CDMO Introduction
11.16.4 Almac Group Revenue in Chemical CDMO Business (2018-2023)
11.16.5 Almac Group Recent Development
11.17 Jubilant Pharmova
11.17.1 Jubilant Pharmova Company Detail
11.17.2 Jubilant Pharmova Business Overview
11.17.3 Jubilant Pharmova Chemical CDMO Introduction
11.17.4 Jubilant Pharmova Revenue in Chemical CDMO Business (2018-2023)
11.17.5 Jubilant Pharmova Recent Development
11.18 Cambrex
11.18.1 Cambrex Company Detail
11.18.2 Cambrex Business Overview
11.18.3 Cambrex Chemical CDMO Introduction
11.18.4 Cambrex Revenue in Chemical CDMO Business (2018-2023)
11.18.5 Cambrex Recent Development
11.19 Siegfried Holding AG
11.19.1 Siegfried Holding AG Company Detail
11.19.2 Siegfried Holding AG Business Overview
11.19.3 Siegfried Holding AG Chemical CDMO Introduction
11.19.4 Siegfried Holding AG Revenue in Chemical CDMO Business (2018-2023)
11.19.5 Siegfried Holding AG Recent Development
11.20 Aenova Group
11.20.1 Aenova Group Company Detail
11.20.2 Aenova Group Business Overview
11.20.3 Aenova Group Chemical CDMO Introduction
11.20.4 Aenova Group Revenue in Chemical CDMO Business (2018-2023)
11.20.5 Aenova Group Recent Development
11.21 Samsung BioLogics
11.21.1 Samsung BioLogics Company Detail
11.21.2 Samsung BioLogics Business Overview
11.21.3 Samsung BioLogics Chemical CDMO Introduction
11.21.4 Samsung BioLogics Revenue in Chemical CDMO Business (2018-2023)
11.21.5 Samsung BioLogics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
